HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul A Andrews Selected Research

cobra cytotoxin I

12/2013Considerations for the nonclinical safety evaluation of antibody drug conjugates for oncology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul A Andrews Research Topics

Disease

1Neoplasms (Cancer)
12/2013
1Weight Loss (Weight Reduction)
01/2010
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
01/2010

Drug/Important Bio-Agent (IBA)

1Cytotoxins (Cytolysins)IBA
12/2013
1cobra cytotoxin IIBA
12/2013
1Histone Deacetylase InhibitorsIBA
01/2010
1VorinostatFDA Link
01/2010